Randomized double-blind trial reports lanreotide assessment in non-functioning pituitary macroadenoma patients, highlighting targeted endocrine therapy.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Boertien et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: